Real impact and reasons for anti-VEGF treatment delay during Covid-19 pandemic lockdown in neovascular age-related macular degeneration: A national study

被引：0
|
作者：
Zarranz-Ventura, Javier [1 ,2 ]
Pinazo, Roberto Gallego [3 ]
Martin-Pinardel, Ruben [2 ]
Gomez, Laia [4 ]
Escobar, Jose Juan [5 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Catalunya, Spain
[2] Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalunya, Spain
[3] Clin Oftalvist, Valencia, Valencia, Spain
[4] Novartis Pharmaceut, Barcelona, Spain
[5] Hosp Maig, Barcelona, Catalunya, Spain
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
341
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration
    Javier Zarranz-Ventura
    José J. Escobar-Barranco
    Laia Gómez-Baldó
    Roberto Gallego-Pinazo
    Ophthalmology and Therapy, 2023, 12 : 2537 - 2555
  • [2] Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration
    Zarranz-Ventura, Javier
    Escobar-Barranco, Jose J.
    Gomez-Baldo, Laia
    Gallego-Pinazo, Roberto
    Study Investigators
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (05) : 2537 - 2555
  • [3] Effects of the COVID-19 pandemic on neovascular age-related macular degeneration and response to delayed Anti-VEGF treatment
    Yeter, D. Y.
    Dursun, D.
    Bozali, E.
    Ozec, A., V
    Erdogan, H.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (03): : 299 - 306
  • [4] Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
    Borrelli, Enrico
    Foti, Claudio
    Ulla, Lorena
    Porreca, Annamaria
    Introini, Ugo
    Grassi, Maria Oliva
    Viggiano, Pasquale
    Peronetti, Mario
    Toscani, Rebecca
    Boscia, Giacomo
    Termite, Alba Chiara
    Gennaro, Carlo
    Marolo, Paola
    Boscia, Francesco
    Bandello, Francesco
    Reibaldi, Michele
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2025,
  • [5] ANTI-VEGF TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN AUSTRALIA
    Finger, Robert
    Fotis, Kathy
    Cummins, Rob
    Heraghty, Julie
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 14 - 14
  • [6] Neovascular age-related macular degeneration and anti-VEGF nonresponders
    Sheybani, Arsham
    Almony, Arghavan
    Blinder, Kevin J.
    Shah, Gaurav K.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
  • [7] Two-Year Follow-Up Study of Patients with Neovascular Age-Related Macular Degeneration Undergoing Anti-VEGF Treatment during the COVID-19 Pandemic
    Kim, Jae-Gon
    Kim, Yu Cheol
    Kang, Kyung Tae
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [8] Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration
    Marco Nassisi
    Francesco Pozzo Giuffrida
    Paolo Milella
    Simone Ganci
    Andrea Aretti
    Claudia Mainetti
    Laura Dell’Arti
    Chiara Mapelli
    Francesco Viola
    BMC Ophthalmology, 23
  • [9] Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration
    Nassisi, Marco
    Pozzo Giuffrida, Francesco
    Milella, Paolo
    Ganci, Simone
    Aretti, Andrea
    Mainetti, Claudia
    Dell'Arti, Laura
    Mapelli, Chiara
    Viola, Francesco
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [10] Adjuvant radiotherapy during anti-VEGF in neovascular age-related macular degeneration
    Rating, P.
    Freimuth, M. -A.
    Stuschke, M.
    Bornfeld, N.
    OPHTHALMOLOGE, 2017, 114 (04): : 370 - 374
12345